Tremfya going after psoriatic arthritis

[Fred]

Update: The National Institute for Health and Care Excellence (NICE) UK have issued final appraisal for Tremfya (guselkumab) to be used  for treating psoriatic arthritis.

Quote:

---

Tremfya can be used for treating active psoriatic arthritis (PsA) in adults who have not responded well to disease-modifying antirheumatic drug (DMARD) therapy or who cannot tolerate them.

The recommendation is only for patients if they have the following:

• Peripheral arthritis with three or more tender joints and three or more swollen joints
     
  
• Moderate to severe psoriasis (a body surface area of at least 3% affected by plaque psoriasis and a Psoriasis Area and Severity Index score greater than 10)
     
  
• Had two conventional DMARDs and at least one biological DMARD